
Sunil Sharma MD
Gastrointestinal Cancer, Hematologic Oncology, Clinical Pharmacology
Virginia G Piper Distinguished Chair in Innovative Cancer Research, Director of Center for Translational Science at Honor Health Research Institute, Professor in School of Medicine and Advanced Medical Engineering, Arizona State University
Join to view full profile
10510 N 92nd Street Suite 200Scottsdale, AZ 85258
Phone+1 480-323-1350
Dr. Sharma is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sunil Sharma is an oncology specialist based in Scottsdale, AZ, with subspecialties in gastrointestinal cancer, hematologic oncology, and clinical pharmacology. He completed his residency in internal medicine at Michael Reese Hospital and Medical Center and his fellowship in hematology and medical oncology at the University of Texas Health Science Center. He has served in leadership roles such as Director of Translational Research and Drug Discovery at HonorHealth Scottsdale Shea Medical Center and as Division Chief at the Huntsman Cancer Institute. Dr. Sharma has extensive experience in colorectal and pancreatic cancer, hematologic oncology, and clinical research, contributing to publications on topics such as KRAS inhibitor resistance and RNA modification in leukemic stem cells. He has been involved in several significant clinical trials and has received CMS Meaningful Use Stage Certifications from Epic Systems Corporation.
Education & Training
Creighton University School of Medicine-PhoenixResidency, Gastroenterology, 2016 - 2022
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 1995 - 1998
Michael Reese Hospital/University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1990 - 1993
Delhi University College of Medical SciencesClass of 1988
Certifications & Licensure
AZ State Medical License 2017 - 2028
UT State Medical License 2009 - 2028
CA State Medical License 2018 - 2027
NV State Medical License 2004 - 2027
NY State Medical License 1998 - 2027
TX State Medical License 1995 - 2027
GA State Medical License 1993 - 1997
American Board of Internal Medicine Medical Oncology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- Extended Follow-Up of Botensilimab Plus Balstilimab in an Expanded Cohort of Microsatellite-Stable Metastatic Colorectal Cancer Without Active Liver Metastases.Benjamin L Schlechter, Marwan G Fakih, Apostolia M Tsimberidou, Andrea J Bullock, Agustin Pimentel
Clinical Cancer Research. 2026-08-28 - A phase II clinical trial of albumin-bound paclitaxel, cisplatin, gemcitabine (NABPLAGEM), and paricalcitol as neoadjuvant therapy in pancreatic cancer.Alexa F Viniotis, Gayle S Jameson, Betsy C Wertheim, Denise J Roe, Keehoon Lee
The Oncologist. 2026-06-06 - 5 citationsA randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic can...Gayle S Jameson, Denise J Roe, Erkut Borazanci, Diana L Hanna, Caroline G P Roberts
Cancer. 2026-03-15
Press Mentions
TGen, Ashion and HonorHealth: Organoids Can Help Pinpoint the Right Therapies for Cancer PatientsJune 22nd, 2020
Arizona’s HonorHealth Research Institute First to Investigate Combination of Atovaquone & Azithromycin in COVID-19 PatientsMay 7th, 2020
24 Pancreatic Cancer Patients Will Attend Charity Golf EventOctober 26th, 2019
Other Languages
- Hindi
External Links
- We fight pancreatic cancerhttps://www.12news.com/article/news/tgen-in-phoenix-helping-fight-pancreatic-cancer/75-1488eb7d-ba79-487d-a7ab-bffc096baf63
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:






